These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33201570)

  • 1. The association between non-alcoholic fatty liver disease (with or without metabolic syndrome) and extrahepatic cancer development.
    Yamamoto K; Ikeya T; Okuyama S; Fukuda K; Kobayashi D
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1971-1978. PubMed ID: 33201570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the Frequency of Daily Toothbrushing and Development of Nonalcoholic Fatty Liver Disease.
    Yamamoto K; Ikeya T; Okuyama S; Fukuda K; Kobayashi D
    Dig Dis; 2021; 39(6):646-652. PubMed ID: 33535206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
    Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
    BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.
    Cho YK; Kang YM; Yoo JH; Lee J; Lee SE; Yang DH; Kang JW; Park JY; Jung CH; Kim HK; Lee WJ
    Sci Rep; 2018 Aug; 8(1):12004. PubMed ID: 30104707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.
    Allen AM; Hicks SB; Mara KC; Larson JJ; Therneau TM
    J Hepatol; 2019 Dec; 71(6):1229-1236. PubMed ID: 31470068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
    Han AL
    BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome.
    Bae JC; Kim SK; Han JM; Kwon S; Lee DY; Kim J; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    Diabetes Res Clin Pract; 2017 Jul; 129():136-143. PubMed ID: 28527304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
    Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
    Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Liang C; Yu Z; Bai L; Hou W; Tang S; Zhang W; Chen X; Hu Z; Duan Z; Zheng S
    Front Endocrinol (Lausanne); 2022; 13():869579. PubMed ID: 35937795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features.
    Bullón-Vela V; Abete I; Tur JA; Pintó X; Corbella E; Martínez-González MA; Toledo E; Corella D; Macías M; Tinahones F; Fitó M; Estruch R; Ros E; Salas-Salvadó J; Daimiel L; Zulet MA; Martínez JA;
    Nutrition; 2020 Mar; 71():110620. PubMed ID: 31838461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
    Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
    Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
    Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
    Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):176-180. PubMed ID: 28381382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN).
    Vusirikala A; Thomas T; Bhala N; Tahrani AA; Thomas GN; Nirantharakumar K
    BMC Endocr Disord; 2020 Jun; 20(1):96. PubMed ID: 32605642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental models of metabolic and alcoholic fatty liver disease.
    Buyco DG; Martin J; Jeon S; Hooks R; Lin C; Carr R
    World J Gastroenterol; 2021 Jan; 27(1):1-18. PubMed ID: 33505147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
    Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
    Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.